Prospective Transcriptomic Pathway Analysis of Human Lymphatic Vascular Insufficiency: Identification and Validation of a Circulating Biomarker Panel

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Lin, Shin ^a   Kim, Jeanna ^a   Lee, Mi Joung ^a   Roche, Leslie ^a   Yang, Nancy L ^a   Tsao, Philip S ^a   Rockson, Stanley G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 10; INTERLEUKIN 4; LEPTIN; LYMPHOTOXIN; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LIPID METABOLISM; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM DISEASE; LYMPHATIC VASCULAR INSUFFICIENCY; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN SECRETION; PUNCH BIOPSY; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BIOPSY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LYMPHEDEMA; MALE; MIDDLE AGED; PROTEOMICS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SIGNAL TRANSDUCTION;

MURINAE;

EID: 84871326758     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052021     Document Type: Article

References (49)

1. Rockson S, (2008) A Population-based assessment of the problem of lymphatic disease. Lymphat Res Biol 6: 1-2.
2. Cheung L, Han J, Beilhack A, Joshi S, Wilburn P, et al. (2006) An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis. BioDrugs 20: 363-370.
3. Rockson SG, (2010) Current concepts and future directions in the diagnosis and management of lymphatic vascular disease. Vasc Med 15: 223-231.
4. Zampell JC, Aschen S, Weitman ES, Yan A, Elhadad S, et al. (2012) Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation. Plast Reconstr Surg 129: 825-834.
5. Choi I, Lee S, Hong YK, (2012) The new era of the lymphatic system: no longer secondary to the blood vascular system. Cold Spring Harb Perspect Med 2: a006445.
6. National Heart Lung and Blood Institute (2007) Trans-NIH Working Group Meeting Lymphatic Research.
7. Shin WS, Rockson SG, (2008) Animal models for the molecular and mechanistic study of lymphatic biology and disease. Ann N Y Acad Sci 1131: 50-74.
8. Shin WS, Szuba A, Rockson SG, (2003) Animal models for the study of lymphatic insufficiency. Lymphat Res Biol 1: 159-169.
9. Schneider M, Ny A, Ruiz de Almodovar C, Carmeliet P, (2006) A new mouse model to study acquired lymphedema. PLoS Med 3: e264.
10. Tabibiazar R, Cheung L, Han J, Swanson J, Beilhack A, et al. (2006) Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med 3: e254.
11. Sitzia J, (1995) Volume measurement in lymphoedema treatment: examination of formulae. Eur J Cancer Care (Engl) 4: 11-16.
12. Ward LC, (2006) Bioelectrical impedance analysis: proven utility in lymphedema risk assessment and therapeutic monitoring. Lymphat Res Biol 4: 51-56.
13. Ward LC, Dylke E, Czerniec S, Isenring E, Kilbreath SL, (2011) Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy. Lymphat Res Biol 9: 47-51.
14. Ward LC, Dylke E, Czerniec S, Isenring E, Kilbreath SL, (2011) Reference ranges for assessment of unilateral lymphedema in legs by bioelectrical impedance spectroscopy. Lymphat Res Biol 9: 43-46.
15. Team RDC (2011) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
16. Paquet A, Yang JYH (2010) arrayQuality: Assessing array quality on spotted arrays. 2010 ed.
17. Yang Y, Paquet A, Dudoit S (2009) marray: Exploratory analysis for two-color spotted microarray data.
18. Smyth G (2005) Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor New York: Springer. 397-420.
19. de Boer T (2007) GeneSpring: GeneSpring R Integration Functions.
20. Fan R-E, Chang K-W, Hsieh C-J, Wang W-R, Lin C-J, (2008) LIBLINEAR: A Library for Large Linear Classification. Journal of Machine Learning Research 9: 1871-1874.
21. Sing T, Sander O, Beerenwinkel N, Lengauer T, (2005) ROCR: visualizing classifier performance in R. Bioinformatics. 21: 3940-3941.
22. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, et al. (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12: 77.
23. Jin DP, An A, Liu J, Nakamura K, Rockson SG, (2009) Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization. Lymphat Res Biol 7: 47-57.
24. Tabibiazar R, Wagner RA, Deng A, Tsao PS, Quertermous T, (2006) Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice. Physiol Genomics 25: 194-202.
25. Lopez E, Madero L, Lopez-Pascual J, Latterich M, (2012) Clinical Proteomics and OMICS clues useful in Translational Medicine Research. Proteome Sci 10: 35.
26. Boschetti E, Chung MC, Righetti PG, (2012) "The quest for biomarkers": are we on the right technical track? Proteomics Clin Appl 6: 22-41.
27. Ardigo D, Assimes TL, Fortmann SP, Go AS, Hlatky M, et al. (2007) Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics 31: 402-409.
28. Chen MM, Ashley EA, Deng DX, Tsalenko A, Deng A, et al. (2003) Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108: 1432-1439.
29. Ho M, Yang E, Matcuk G, Deng D, Sampas N, et al. (2003) Identification of endothelial cell genes by combined database mining and microarray analysis. Physiol Genomics 13: 249-262.
30. King JY, Ferrara R, Tabibiazar R, Spin JM, Chen MM, et al. (2005) Pathway analysis of coronary atherosclerosis. Physiol Genomics 23: 103-118.
31. Spin JM, Nallamshetty S, Tabibiazar R, Ashley EA, King JY, et al. (2004) Transcriptional profiling of in vitro smooth muscle cell differentiation identifies specific patterns of gene and pathway activation. Physiol Genomics 19: 292-302.
32. Tabibiazar R, Wagner RA, Ashley EA, King JY, Ferrara R, et al. (2005) Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease. Physiol Genomics 22: 213-226.
33. Tabibiazar R, Wagner RA, Spin JM, Ashley EA, Narasimhan B, et al. (2005) Mouse strain-specific differences in vascular wall gene expression and their relationship to vascular disease. Arterioscler Thromb Vasc Biol 25: 302-308.
34. Rockson S, (2007) The future development of lymphatic research and biology: what is needed. Lymphat Res Biol 5: 217-218.
35. Zampell JC, Yan A, Avraham T, Andrade V, Malliaris S, et al. (2011) Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema. Am J Physiol Cell Physiol 300: C1107-1121.
36. Rockson SG, (2006) Addressing the unmet needs in lymphedema risk management. Lymphat Res Biol 4: 42-46.
37. Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona G, (2001) Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer 92: 1783-1787.
38. Rockson SG, (1998) Precipitating factors in lymphedema: myths and realities. Cancer 83: 2814-2816.
39. Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, et al. (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112: 2809-2819.
40. Nakamura K, Radhakrishnan K, Wong YM, Rockson SG, (2009) Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice. PLoS One 4: e8380.
41. Hwang JH, Kim IG, Lee JY, Piao S, Lee DS, et al. (2011) Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel. Biomaterials 32: 4415-4423.
42. Lahteenvuo M, Honkonen K, Tervala T, Tammela T, Suominen E, et al. (2011) Growth factor therapy and autologous lymph node transfer in lymphedema. Circulation 123: 613-620.
43. Choi I, Lee S, Kyoung Chung H, Suk Lee Y, Eui Kim K, et al. (2012) 9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema. Circulation 125: 872-882.
44. Cooke JP, (2012) Lymphangiogenesis: a potential new therapy for lymphedema? Circulation 125: 853-855.
45. Olszewski WL, Jamal S, Manokaran G, Lukomska B, Kubicka U, (1993) Skin changes in filarial and non-filarial lymphoedema of the lower extremities. Trop Med Parasitol 44: 40-44.
46. Avraham T, Clavin NW, Daluvoy SV, Fernandez J, Soares MA, et al. (2009) Fibrosis is a key inhibitor of lymphatic regeneration. Plast Reconstr Surg 124: 438-450.
47. Avraham T, Daluvoy S, Zampell J, Yan A, Haviv YS, et al. (2010) Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair. Am J Pathol 177: 3202-3214.
48. Zampell JC, Avraham T, Yoder N, Fort N, Yan A, et al. (2012) Lymphatic function is regulated by a coordinated expression of lymphangiogenic and anti-lymphangiogenic cytokines. Am J Physiol Cell Physiol 302: C392-404.
49. Aschen S, Zampell JC, Elhadad S, Weitman E, De Brot M, et al. (2012) Regulation of adipogenesis by lymphatic fluid stasis: part II. Expression of adipose differentiation genes. Plast Reconstr Surg 129: 838-847.